Male Infertility – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Male Infertility – Drugs In Development, 2024 report and make more profitable business decisions.
Male infertility refers to a male’s inability to achieve a pregnancy in a fertile female. Male infertility is caused by low sperm production, immobile sperm, or blockages that prevent the delivery of sperm. Symptoms include pain, swelling, or a lump in the testicle area. Predisposing factors include smoking, alcohol use, overweight, toxin exposure, and certain medical conditions including tumors and chronic illnesses. Treatment includes surgery and hormone replacement therapy.
The Male Infertility drugs in development market research report provide comprehensive information on the therapeutics under development for Male Infertility, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Male Infertility and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Male Infertility | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 17 molecules, with 13 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Male Infertility therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Male Infertility pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Male Infertility treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Amgen IncAprilbio Co Ltd
Asia Stem Cell Regenerative Pharmaceutical Co Ltd
Beijing FuKangren Bio-pharm Tech Co Ltd
Ben-Gurion University of the Negev
Conduit Pharmaceuticals Inc
Ferring International Center SA
Igyxos SA
Neuromagen Pharma Ltd
Park of Active Molecules
Prokrea BCN SL
Shanghai Jing Ze Biotechnology Co Ltd
St George Street Capital Ltd
University of Bonn
University of Dundee
University of Pittsburgh
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Male Infertility reports